aXichem signs agreement with Caldic Denmark regarding marketing and distribution of aXivite in the Nordic region
aXichem AB (publ), a developer of natural analogue industrial compounds, has signed a marketing and distribution agreement with the Caldic Denmark, a full-service innovative solution provider for the Food, Personal Care, Pharmaceutical and Industrial markets in the Nordics. Under the agreement Caldic Denmark will have the exclusive right to market and sell aXichem’s unique synthetic capsaicin product, aXivite, in Denmark, Finland, Norway and Sweden. aXivite is proven in clinical studies to have a positive effect on gut health as well as metabolism, and its thermogenic effect supports an improved body composition. aXivite has an excellent safety profile which makes it attractive to both producers and consumers.
“I am very pleased to add Caldic’s very strong brand to aXichem’s amazing global network of distributors. We are happy to have Caldic represent aXichem and aXivite in the Nordics. Caldic has the resources and knowledge to harness this growing market in a region where the interest in health and a healthy lifestyle continue to increase.”, says Lucas Altepost, vice President and VP Sales and Marketing at aXichem.
“We are excited about the collaboration with aXichem and the opportunity to introduce aXivite in the Nordic region. aXivite has the potential to fit into several of our targeted market segments. I’m looking forward to put this well documented unique ingredient into the hands of our technical sales team, with the aim to introduce a market ready product during 2022.”, says Niklas Ekman, Managing Director, Industrial, Health and Personal Care.
Caldic has four sales offices in the Nordic region, it is headquartered in Rotterdam, Netherlands, and has more than 40 locations operating around the world. The total market for nutrition products in Denmark, Finland, Norway and Sweden reached almost 800 million Euro in 2020 according to Euromonitor.
This press release was submitted by the contact person below on 22 November 2021, at 13:15 CET.
Torsten Helsing, VD i aXichem, 046-780 06 73. E-post: torsten.helsing@axichem.se
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenyl capsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, nutrition and supplements, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se